功能性口香糖对持续注意力和情绪的直接和残留影响
Emily Haworth1, Crystal F Haskell-Ramsay2
1Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Nutritional neuroscience
|July 23, 2024
概括
有或没有功能成分的口香糖,改善注意力表现. 与普通口香糖相比,将罗迪奥拉和B族维生素添加到口香糖中并没有进一步提高认知效益.
科学领域:
- 认知神经科学 认知神经科学
- 营养科学 营养科学
- 心理药理学 心理药理学
背景情况:
- 口香糖的消费与认知功能的改善有关,特别是持续的注意力.
- 众所周知,功能性成分,如Rhodiola rosea和B族维生素,可以单独增强认知和情绪.
- 这些功能成分在口香糖中的综合作用以前没有被研究过.
研究的目的:
- 为了评估含有Rhodiola rosea和B族维生素的功能性口香糖对认知和情绪的影响.
- 为了比较功能性口香糖与普通口香糖和安慰剂对照.
主要方法:
- 采用了随机,安慰剂控制,双盲,平衡的交叉研究设计.
- 36名健康的年轻人参与了这项研究.
- 注意力和情绪的测量在基线,时和后一个小时被评估.
主要成果:
- 与安慰剂相比,功能性和定期的口香糖都显著减少了与安慰剂相比,数字警任务中的错误.
- 这些注意力改善在时和后都被观察到.
- 从将罗迪奥拉和B族维生素纳入口香糖中没有发现任何额外的认知益处.
结论:
- 口香糖本身,无论功能成分如何,都能提高注意力.
- 在这项研究中,添加Rhodiola rosea和B族维生素的口香糖并没有提供额外的认知优势.
- 未来的研究应该探索各种类型的安慰剂,并调查性别差异和强度的影响.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
51
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
51
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
114
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
114
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


